Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Crescita Therapeutics

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Second Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita to Acquire Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Reports First Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Q4 and Fiscal 2023 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Second Quarter 2023 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports First Quarter 2022 Results
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
From Crescita Therapeutics
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Reports Second Quarter 2021 Results and Provides Corporate Update
From Crescita Therapeutics
Via Business Wire
Tickers TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Crescita Reports First Quarter 2021 Results
From Crescita Therapeutics
Via Business Wire
Tickers OTC TSX:CTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.